ConductScience.org, home

Paper20157080

Predictors of occult nodal metastasis in patients with thin melanoma.

Faries MB and 4 others. Arch Surg, 2010. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Predictors of occult nodal metastasis in patients with thin melanoma. Papers, record 20157080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20157080

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predictors of occult nodal metastasis in patients with thin melanoma.
PubMed
Journal
Arch Surg
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Faries MBMark B
2Wanek LALeslie A
3Elashoff DDavid
4Wright BEByron E
5Morton DLDonald L

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lymph Node ExcisionMajor topic
MelanomaMajor topic
Neoplasm Recurrence, LocalMajor topic
Skin NeoplasmsMajor topic
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Child
Cohort Studies
Databases, Factual
Female
Humans
Incidence
Male
Middle Aged
Retrospective Studies
Risk Factors
Sex Factors
Survival Analysis
Young Adult

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA029605NCI NIH HHSUnited StatesP01CA029605PubMed and NIHNIH RePORTER
CA12582NCI NIH HHSUnited StatesP01CA012582PubMed and NIHNIH RePORTER

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114605613Cost-effectiveness of sentinel lymph node biopsy in thin melanomas.Surgery2003https://conductscience.org/library/papers/14605613PubMed
214530724Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.Ann Surg2003https://conductscience.org/library/papers/14530724PubMed
317005948Sentinel-node biopsy or nodal observation in melanoma.N Engl J Med2006https://conductscience.org/library/papers/17005948PubMed
43942987Recurrence potential of thin primary melanomas.Cancer1986https://conductscience.org/library/papers/3942987PubMed
516258494Sentinel node biopsy for thin melanomas: which patients should be considered?Cancer Control2005https://conductscience.org/library/papers/16258494PubMed
616418885American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.Ann Surg Oncol2006https://conductscience.org/library/papers/16418885PubMed
715383424Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).Ann Surg Oncol2004https://conductscience.org/library/papers/15383424PubMed
814530725
Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
Ann Surg2003https://conductscience.org/library/papers/14530725PubMed
912663722Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.J Clin Oncol2003https://conductscience.org/library/papers/12663722PubMed
1011251950Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.Cancer2001https://conductscience.org/library/papers/11251950PubMed
1116523360Predictors of regional nodal disease in patients with thin melanomas.Ann Surg Oncol2006https://conductscience.org/library/papers/16523360PubMed
1214993019Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.Ann Surg Oncol2004https://conductscience.org/library/papers/14993019PubMed
1310894142Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy.Ann Surg Oncol2000https://conductscience.org/library/papers/10894142PubMed
1416258103Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.J Clin Oncol2005https://conductscience.org/library/papers/16258103PubMed
1515864482Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.Ann Surg Oncol2005https://conductscience.org/library/papers/15864482PubMed
1617146784The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.Cancer2007https://conductscience.org/library/papers/17146784PubMed
1718794428Importance of sentinel lymph node biopsy in patients with thin melanoma.Arch Surg2008https://conductscience.org/library/papers/18794428PubMed
1812640499Vertical growth phase and positive sentinel node in thin melanoma.Braz J Med Biol Res2003https://conductscience.org/library/papers/12640499PubMed
1910819365Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.Ann Surg Oncol2000https://conductscience.org/library/papers/10819365PubMed
2010091790Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.Cancer1999https://conductscience.org/library/papers/10091790PubMed

See all 28 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42588673Thin Nevus-Associated Melanoma: Beyond MIA Score Risk Stratification.Cancers (Basel)2026https://conductscience.org/library/papers/42588673PubMed
40900446A deep learning-clinical nomogram hybrid for predicting sentinel lymph node metastasis in melanoma.J Eur Acad Dermatol Venereol2026https://conductscience.org/library/papers/40900446PubMed
39518065Selective Sentinel Node Dissection in Melanoma with Trends and Future Directions.Cancers (Basel)2024https://conductscience.org/library/papers/39518065PubMed
36259947Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma.Cancer Discov2023https://conductscience.org/library/papers/36259947PubMed
36159108Dermoscopy for Cutaneous Melanoma: Under the Eye of Both the Dermatologist and the Legal Doctor.Dermatol Pract Concept2022https://conductscience.org/library/papers/36159108PubMed
32167862Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.J Clin Oncol2020https://conductscience.org/library/papers/32167862PubMed
31260100Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31260100PubMed
30181807Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile.Oncotarget2018https://conductscience.org/library/papers/30181807PubMed
29641692Prognostic factors for metastasis in cutaneous melanoma.An Bras Dermatol2018https://conductscience.org/library/papers/29641692PubMed
27807729Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.Ann Surg Oncol2017https://conductscience.org/library/papers/27807729PubMed
27671840Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.Cancer Med2016https://conductscience.org/library/papers/27671840PubMed
24610543Thin melanoma and late recurrences: it is never too thin and never too late.Med Oncol2014https://conductscience.org/library/papers/24610543PubMed
24369020Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.Biomed Res Int2013https://conductscience.org/library/papers/24369020PubMed
22766986Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.Ann Surg Oncol2012https://conductscience.org/library/papers/22766986PubMed
22469345Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota.Mayo Clin Proc2012https://conductscience.org/library/papers/22469345PubMed
20512942Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.J Surg Oncol2010https://conductscience.org/library/papers/20512942PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20157080

GET https://conductscience.org/api/papers/v1/20157080/references?page=2